drugset / Trial / NCT07058974

A Study of Exercise and Pharmacologic Intervention on Systemic Inflammation

NCT07058974

Phase 1 Recruiting 22 enrolled Icahn School of Medicine at Mount Sinai
RandomizedParallel-groupOpen-labelPrevention

Summary

This is a study assessing the feasibility of performing an anti-aging intervention which is a combination of an exercise regimen, spermidine supplementation, and either rapamycin or lamivudine.

Timeline

Start
2025-08-25
Primary completion
2026-07-01
Completion
2026-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Lamivudine Other / unclassified
Subject Sirolimus Small molecule

Indications

No indication recorded.